{
  "status" : "final",
  "category" : {
    "text" : "Laboratory",
    "coding" : [
      {
        "system" : "http://hl7.org/fhir/observation-category",
        "display" : "Laboratory",
        "code" : "laboratory"
      }
    ]
  },
  "issued" : "2021-11-15T14:46:00Z",
  "id" : "TNTb73y2NUnhqLlmO.xHMs73YzII4fziCeYx0k.m5.zbPstnWaLoeg4xsITbmZ5a.B",
  "code" : {
    "text" : "HX LDL-CHOLESTEROL"
  },
  "valueQuantity" : {
    "code" : "mg/dL",
    "value" : 52,
    "system" : "http://unitsofmeasure.org",
    "unit" : "mg/dL"
  },
  "subject" : {
    "display" : "Lopez, James Joel",
    "reference" : "https://epicproxy.et0905.epichosted.com/FHIRProxy/api/FHIR/DSTU2/Patient/TrS7pTeyWII9cw-xxl5jDrPczC4c5dkg8XOYg4BocZ84B"
  },
  "comments" : "Treatment Goals:Extreme Risk:       <55 mg/dLVery High Risk:     <70 mg/dLHigh Risk:          <100 mg/dLModerate Risk:      <100 mg/dLLow Risk:           <130 mg/dLAmerican Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for management of dyslipidemia and prevention of cardiovascular disease.  Endocrine Practice Vol 23 (Sup 2) April 2017.Acceptable:            <100 mg/dLNear Optimal:          100-129 mg/dLBorderline High:       130-159 mg/dLHigh:                  160-189 mg/dLVery High:             >189 mg/dLHigh Blood Cholesterol ATP III Guidelines At-A-Glance Quick Desk Reference.  National Cholesterol Education Program NIH Publication No. 01-3305 May 2001.",
  "effectiveDateTime" : "2021-11-15T14:46:00Z",
  "referenceRange" : [
    {
      "text" : "<100"
    }
  ],
  "resourceType" : "Observation"
}